Unlock instant, AI-driven research and patent intelligence for your innovation.
A combination drug for the treatment of b-cell lymphoma
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A lymphoma and B cell technology, applied in the direction of drug combination, antineoplastic drugs, pharmaceutical formulations, etc., to achieve the effect of solving expensive and good therapeutic effects
Inactive Publication Date: 2018-04-10
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0024] Raw materials in the following proportions by weight: 20 parts of raw astragalus, 10 parts of Jiaobaizhu, 12 parts of Sophora flavescens, 12 parts of Asparagus, 12 parts of Fangfeng, 12 parts of Scrophulariaceae, 10 parts of Bergamot, 20 parts of Spatholobus, Danpi 15 parts, 12 parts of donkey-hide gelatin beads, 15 parts of Baiying, 10 parts of Anemarrhena, 15 parts of golden buckwheat, mix well, then add 3000mL of water to heat, after boiling, replace it with a slow fire and boil until the remaining liquid is 300mL, stop the fire and cool down, then Filter to obtain the filtrate. The patient took 30 mL of the obtained filtrate half an hour before meals every day, and insisted on taking it for 30 days.
Embodiment 2
[0026] Raw materials in the following proportions by weight: 15 parts of raw astragalus, 8 parts of Jiaobaizhu, 10 parts of Sophora flavescens, 10 parts of Radix Asparagus, 10 parts of Fangfeng, 12 parts of Scrophulariaceae, 10 parts of Bergamot, 15 parts of Spatholobus, Danpi 10 parts, 10 parts of donkey-hide gelatin beads, 10 parts of Baiying, 8 parts of Anemarrhena, and 10 parts of golden buckwheat are mixed evenly, then add 3000mL of water for heating, after boiling, change to simmering until the remaining liquid is 300mL, stop the fire and cool down, and then Filter to obtain the filtrate. The patient took 30 mL of the obtained filtrate half an hour before meals every day, and insisted on taking it for 30 days.
Embodiment 3
[0028] Raw materials in the following proportions by weight: 15 parts of raw astragalus, 12 parts of Jiaobaizhu, 10 parts of Sophora flavescens, 14 parts of Asparagus, 11 parts of Fangfeng, 11 parts of Scrophulariaceae, 11 parts of Bergamot, 23 parts of Spatholobus, Danpi 18 parts, 11 parts of donkey-hide gelatin beads, 18 parts of Baiying, 15 parts of Anemarrhena, 20 parts of golden buckwheat, mix evenly, then add 3000mL of water to heat, after boiling, change to slow fire and cook until the remaining liquid is 300mL, stop the fire and cool down, then Filter to obtain the filtrate. The patient took 30 mL of the obtained filtrate half an hour before meals every day, and insisted on taking it for 30 days.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a combined medicine for treating B-celllymphoma, which comprises the following components in parts by weight: 15-23 parts of raw astragalus, 8-15 parts of Jiaobaizhu, 10-15 parts of sophora flavescens, and 10-15 parts of asparagus , 10-15 parts of Fangfeng, 10-15 parts of Scrophulariaceae, 8-12 parts of Bergamot, 15-25 parts of Caulis Spatholobus, 10-20 parts of paeonol, 10-15 parts of donkey-hide gelatin beads, 10-20 parts of Baiying, 8 to 15 parts of mother, 10 to 20 parts of golden buckwheat. The traditional Chinese medicine combination medicine provided by the invention has a good therapeutic effect on human B-celllymphoma, and long-term use will not cause secondary damage to the human body. The components of the medicine composition are common and the medicine is easy to obtain, which solves the problem of expensive western medicines.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a combined medicine for treating B-celllymphoma. Background technique [0002] B-cell lymphomas are solid tumors of B-cell origin. Includes Hodgkin's lymphoma and non-Hodgkin's lymphoma. There are many types of Hodgkin's lymphoma, classical Hodgkin's lymphoma and nodular lymphocyte-predominant Hodgkin's lymphoma, which are now considered to be tumors originating from B cells. Diffuse large B-cell lymphoma, follicular lymphoma, mucosa-associated lymphoid tissue lymphoma (MALT), small lymphocytic lymphoma / chronic lymphocytic leukemia, mantle cell lymphoma (MCL) 5 types of B-cell non-Hodgkin Lymphoma is the most common, accounting for 3 / 4 of non-Hodgkin's lymphomas. The prognosis and treatment of B-cell lymphoma depend on the specific type and stage of the lymphoma. Diffuse large B-cell lymphoma is the most common type of adult lymphoma, with heterogeneity in clinic...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More